Literature DB >> 18846340

Regulation of hypoxic response elements on the expression of vascular endothelial growth factor gene transfected to rat skeletal myoblasts under hypoxic environment.

Lei Xu1, Jiahong Xia, Kailun Zhang, Aini Xie.   

Abstract

The regulation of hypoxic response elements on the expression of vascular endothelial growth factor (VEGF) gene transfected to primary cultured rat skeletal myoblasts under hypoxic environment was investigated. pEGFP-C3-9HRE-CMV-VEGF vector was constructed with molecular biology technique and transfected to primary cultured rat skeletal myoblasts by lipofectamine in vitro. Gene expression of transfected myoblasts was detected by RT-PCR, Western blot and fluorescence microscope under different oxygen concentrations and different hypoxia time. The results showed that in hypoxia group, the VEGF gene bands were seen and with the decrease of oxygen concentrations and prolongation of hypoxia time, the expression of VEGF mRNA was obviously increased. Under hypoxic environment, the expression of VEGF protein in the transfected myoblasts was significantly increased. EGFP was expressed only under hypoxic environment but not under normoxic environment. It was concluded that hypoxia promoter could be constructed with HRE and regulate the expression of VEGF gene under hypoxic and normoxic environment, which could enhance the reliability of gene therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846340     DOI: 10.1007/s11596-008-0517-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

Review 1.  Hypoxia-inducible factor and its biomedical relevance.

Authors:  L Eric Huang; H Franklin Bunn
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

Review 2.  New perspectives in the treatment of damaged myocardium using autologous skeletal myoblasts.

Authors:  Gianluca Rigatelli; Katia Rossini; Vincenzo Vindigni; Francesco Mazzoleni; Giorgio Rigatelli; Ugo Carraro
Journal:  Cardiovasc Radiat Med       Date:  2004 Apr-Jun

3.  Autologous skeletal myoblasts for myocardial regeneration.

Authors:  Tomasz Siminiak; Piotr Kalmucki; Maciej Kurpisz
Journal:  J Interv Cardiol       Date:  2004-12       Impact factor: 2.279

Review 4.  The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.

Authors:  Josep Tabernero
Journal:  Mol Cancer Res       Date:  2007-03       Impact factor: 5.852

Review 5.  Vascular endothelial growth factor (VEGF) in physiological and pathological conditions.

Authors:  Grazyna Chodorowska; Janusz Chodorowski; Andrzej Wysokiński
Journal:  Ann Univ Mariae Curie Sklodowska Med       Date:  2004

6.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

Authors:  M Ziche; L Morbidelli; R Choudhuri; H T Zhang; S Donnini; H J Granger; R Bicknell
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

7.  Myoblast transplantation for heart failure.

Authors:  P Menasché; A A Hagège; M Scorsin; B Pouzet; M Desnos; D Duboc; K Schwartz; J T Vilquin; J P Marolleau
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

8.  Early expression of angiogenesis factors in acute myocardial ischemia and infarction.

Authors:  S H Lee; P L Wolf; R Escudero; R Deutsch; S W Jamieson; P A Thistlethwaite
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

9.  The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.

Authors:  Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Edward R McCluskey
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

10.  Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.

Authors:  D A Taylor; B Z Atkins; P Hungspreugs; T R Jones; M C Reedy; K A Hutcheson; D D Glower; W E Kraus
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.